Treatment options in bulky stage IB cervical carcinoma

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1153-1162

  Petsuksiri, J ^a   Chansilpa, Y ^a   Therasakvichya, S ^a   Suntornpong, N ^a   Thephamongkhol, K ^a   Dankulchai, P ^a   Mahasitthiwat, P ^a   Ieumwananonthachai, N ^a   Veerasarn, V ^a   Sangruchi, S ^a   Pattaranutaporn, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bulky stage IB; Cervical carcinoma; Cervix

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE;

ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYSTERECTOMY; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 55949109070     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2008.01195.x     Document Type: Review

References (61)

1. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer. An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 2004 22 : 872 80.
2. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 340 : 1144 53.
3. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999 17 : 1339 48.
4. Perez CA, Grigsby PW, Nene SM et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992 69 : 2796 806.
5. Toms WW, Eifel PJ, Smith TL et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 1992 491 9.
6. Gauthier P, Gore I, Shingleton HM et al. Identification of histopathologic risk groups in stage IB squamous carcinoma of the cervix. Obstet Gynecol 1985 66 : 569 73.
7. Landoni F, Maneo A, Colombo A et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997 350 : 535 40.
8. Sedlis A, Bundy BN, Rotman MZ et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999 73 : 177 83.
9. Rotman MZ, Sedlis A, Piedmonte MR et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006 65 : 169 76.
10. Hopkins MP, Morely GW. Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 1991 68 : 272 7.
11. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow up. Am J Obstet Gynecol 1975 123 : 535 42.
12. Volterrani F, Feltre L, Sigurta D et al. Radiotherapy versus surgery in the treatment of cervix stage Ib cancer. Int J Radiat Oncol Biol Phys 1983 9 : 1781 4.
13. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasive). Am J Obstet Gynecol 1976 126 : 785 98.
14. Eifel PJ, Morris M, Wharton JT et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994 29 : 9 16.
15. Alvarez RD, Poter ME, Soong SJ et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol 1991 43 : 108 12.
16. Nag S, Chao C, Erikson B et al. The American Brachytherapy Society recommendation for low dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002 52 : 33 48.
17. Milas L, Cox JD. Principles of combining radiation therapy and chemotherapy. In : Cox JD, Ang KK, eds. Radiation oncology rationale, technique, results, 8th edn. St. Louis, MO : Mosby Co, 2003 : 108 24.
18. Perez CA. Uterine cervix. In : Perez CA, Brady LW, eds. Principle and practice in radiation oncology, 3rd edn. Philadelphia, PA : Lippincott-Raven Publishers, 1998 : 1733 834.
19. The Cochrane Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer 2003 39 : 2470 86.
20. Leborgne F, Leborgne JH, Doldan R et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997 37 : 343 50.
21. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation therapy and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999 340 : 1154 61.
22. Keys HM, Bundy BN, Stehman FB et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of Gynecologic Oncology Group. Gynecol Oncol 2003 89 : 343 53.
23. Stehman FB, Ali S, Keys HM et al. Radiation therapy with or without weekly cisplatin for bulky stage IB cervical carcinoma: follow up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007 197 : 503.e1 6.
24. Gallion HH, van Nagell JR Jr, Donaldson ES et al. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 1985 56 : 262 5.
25. Mendenhall WM, McCarty PJ, Morgan LS et al. Stage IB or IIA-B carcinoma of the intact uterine cervix > = 6 cm in diameter, is adjunctive hysterectomy beneficial? Cancer 1984 53 : 2649 54.
26. Perez CA, Grigsby PW, Camel HM et al. Irradiation alone or combined with surgery in stage IB, IIA and IIB carcinoma of the uterine cervix; update of a non randomized comparison. Int J Radiat Oncol Biol Phys 1995 15 : 703 16.
27. Burke TW. Treatment options in stage IB cervical cancer: radical hysterectomy and radiotherapy. Semin Radiat Oncol 1994 4 : 34 40.
28. Eddy GL, Bundy BN, Creasman WT et al. Treatment of bulky stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 2007 106 : 362 9.
29. Napolitano U, Imperato F, Mossa B et al. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long term randomized trial. Eur J Gynecol Oncol 2003 24 : 51 9.
30. Sardi JE, Giaroli A, Sananes C et al. Long term follow up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997 67 : 61 9.
31. Cai HB, Chen HZ, Yin HH. Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res 2006 32 : 315 23.
32. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003 14 : 1278 84.
33. Buda A, Fossati R, Colombo N et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 2005 23 : 4137 45.
34. Termrungruanglert W, Tresukosol D, Vasuratna A et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in bulky squamous cell carcinoma of the cervix stage IB2. Gynecol Oncol 2005 97 : 576 81.
35. Kokawa K, Nishimura R, Fujii T et al. Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix. Anticancer Res 2007 27 : 2721 7.
36. Lerouge D, Touboul E, Lefranc JP et al. Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion. Cancer Radiother 2004 8 : 168 77.
37. Modarress M, Maghami FQ, Golnavaz M et al. Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer 2005 15 : 483 8.
38. Benedetti-Pacini P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from Italian multicenter randomized study. J Clin Oncol 2002 20 : 179 88.
39. Chang TC, Lai CH, Hong JH et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 2000 18 : 1740 7.
40. Fuller AF, Elliott N, Kosloff C et al. Determinants of increased risk of recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989 33 : 34 9.
41. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases ill cervical carcinoma. Obstet Gynecol 1975 46 : 507 10.
42. Dawtlatly R, Lavie O, Cross PA et al. Prognostic factors in surgically treated stage IB-IIB squamous cell carcinoma of the cervix with positive lymph nodes. Int J Gynecol Cancer 1998 8 : 46 7.
43. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990 65 : 1923 7.
44. Naoki T, Noriaki S, Takeda M et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002 81 : 1144 51.
45. Burghardt E, Pickle H, Hass J et al. Prognostic factors and operative treatment of stage IB to IIB cervical cancer. Am J Obstet Gynecol 1987 156 : 988 96.
46. Chung CK, Nahhas WA, Styker JA et al. Analysis of factors contributing to treatment failures to stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980 138 : 550 6.
47. Stitt JA. Use of postoperative irradiation for carcinoma of the cervix. Semin Radiat Oncol 1994 4 : 41 5.
48. Koh WJ, Panwala K, Benjamin G. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol 2000 10 : 51 60.
49. Delgado G, Bundy B, Ziano R et al. Prospective surgical pathological study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Gynecol Oncol 1990 38 : 352 7.
50. Peters WA III., Liu PY, Barrett RJ II. et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000 18 : 1606 13.
51. Monk BJ, Wang J, Im S et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol 2005 96 : 721 8.
52. Koh WJ. Cervical cancer. In : Gunderson LL, Tepper JE, eds. Clinical radiation oncology, 2nd edn. Philadelphia, PA : Elsevier Churchill Livingstone, 2007 : 1323 57.
53. Eifel PJ, Burke TW, Morris M et al. Adenocarcinoma as independent risk factor for disease recurrence in patient with stage IB cervical carcinoma. Gynecol Oncol 1995 59 : 38 44.
54. Nakanishi T, Ishikawa H, Suzuki Y et al. A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol 2000 79 : 289 93.
55. Naoki T, Noriaki S, Takeda M et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002 81 : 1144 51.
56. Grigsby PW, Perez CA, Kuske RR et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol 1988 12 : 289 96.
57. Shingleton HM, Bell MC, Fremgen A et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma of the cervix? Cancer 1995 76 (10 Suppl 1948 55.
58. Kjorstad KE, Bond BE. Stage IB adenocarcinoma of the cervix: metastatic potential and pattern of dissemination. Am J Obstet Gynecol 1984 150 : 297 9.
59. Vizcaino AP, Moreno V, Bosch FX et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinoma. Int J Cancer 1998 75 : 536 45.
60. Steren A, Nguyen HN, Averette HE et al. Radical hysterectomy for stage IB adenocarcinoma of the cervix: the University of Miami experience. Gynecol Oncol 1993 48 : 355 9.
61. Eifel PJ, Burke TW, Morris M et al. Adenocarcinoma as independent risk factor for disease recurrence in patient with stage IB cervical carcinoma. Gynecol Oncol 1995 59 : 38 44.